No Detail Found!

Combination of eudragit EPO with poloxamers for improved solubility and dissolution of Zafirlukast: An evaluation of solid dispersion formulations

Author(s)
Zeeshan Masood Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Muhammad Tayyab Ansari Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Samina Afzal Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Abstract
This study investigated the effect of solid dispersions (SD) on solubility and release of Zafirlukast (ZA) by physical mixture (PM), solvent evaporation (SE) and kneading method (KM) with Eudragit EPO (EPO) as binary component and Poloxamer 188 (P188) and Poloxamer 407 (P407) as ternary components. The binary and ternary systems caused an increase of 322 folds and 356 folds in aqueous solubility of ZA, respectively. Formulations were characterized for solubility, FTIR, PXRD, DSC, SEM and dissolution studies. P407 was found to be an excellent solubility booster in combination with EPO. It was concluded that solubility and dissolution rate of ZA increased significantly when SD of the ZA was prepared by solvent evaporation method (1:7 ratio) using 15% P407 as ternary component.
Publication Details
Page(s) 1923-1928
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP5, Year: 2021

Request the full text from PASTIC

Keywords
solvent evaporation, solubility, solid dispersions, Zafirlukast
References
Agafonov M,Volkova T,Kumeev R,Chibunova E,Terekhova I .2019 .Impact of pluronic F127 on aqueous solubility and membrane permeability of antirheumatic compounds of different structure and polarity. J. Mol. Liq, 274 : 770-777.
Alshehri S,Shakeel F,Ibrahim M,Elzayat E,Altamimi M,Shazly G,Mohsin K,Alkholief M,Alsulays B,Alshetaili A .2017 .Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. PloS One, 12(7) : e0182011.
Barkat MA,Rizwanullah M,Beg S,Pottoo FH,Siddiqui S,Ahmad FJ .2019 .Paclitaxel-loaded nanolipidic carriers with improved oral bioavailability and anticancer activity against human liver carcinoma. AAPS PharmSciTech, 20(2) : 1-14.
Delijewski M and Haneczok J .2021 .AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate. Med, 9 : 100077.
Drašković M,Medarević D,Aleksić I,Parojčić J .2017 .In vitro and in vivo investigation of tastemasking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug Dev, 43(5) : 723-731.
Feng Z,Li M,Wang W .2019 .Improvement of dissolution and tabletability of carbamazepine solid dispersions with high drug loading prepared by hotmelt extrusion. Pharmazie, 74(9) : 523-528.
Gajera BY,Dugar RP,Dave RH .2016 .Formulation development and optimization of ibuprofen poloxamer melt granules using hydrophilic excipients. J. Pharm. Res. Int., 13(6) : 1-19.
Huang S and Williams RO .2018 .Effects of the preparation process on the properties of amorphous solid dispersions. AAPS PharmSciTech, 19(5) : 1971-1984.
Kajdič S,Vrečer F,Kocbek P F .2018 .Preparation of poloxamer-based nanofibers for enhanced dissolution of carvedilol. Eur. J. Pharm. Sci., 117 : 331-340.
Kumar P,Agarwal A,Singh AK,Gautam AK,Chakraborti S,Kumar U,Kumar D,Bhattacharya B,Panda P,Saha B .2019 .Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis. Regul, 109 : 104489.
Lei C,Wu S,Wen C,Li Y,Liu N,Huang J,Li L,Fu M,Liu J .2019 .Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM). Int. Immunopharmacol., 68 : 68-73.
Madsen CM,Boyd B,Rades T,Müllertz A .2016 .Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Eur. J. Pharm. Sci., 91 : 31-39.
McPherson S,Perrier J,Dunn C,Khadra I,Davidson S,Ainousah B,Wilson CG,Halbert G .2020 .Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid. Eur. J. Pharm. Biopharm., 150 : 14-23.
Mehmood HQ,Faran SA,Chaudhry MA,Khalid SH,Khan IU,Hassan W,Ashfaq R,Asghar S R .2019 .An assessment of bioavailability of acrylate based pHsensitive complexes of lovastatin. Pak. J. Pharm. Sci., 32(Suppl) : 1129-1136.
Nanaki S,Eleftheriou RM,Barmpalexis P,Kostoglou M,Karavas E,Bikiaris D .2019 .Evaluation of dissolution enhancement of aprepitant drug in ternary pharmaceutical solid dispersions with Soluplus® and Poloxamer 188 prepared by melt mixing. Sci, 1(2) : 48.
Neeharika M and Jyothi BJ .2021 .Preparation and Evaluation of Zafirlukast Compression Coated Tablets for Chronotherapeutic Drug Delivery. J. Pharm. Res. Int., 33 : 154-166.
Porfiryeva NN,Nasibullin SF,Abdullina SG,Tukhbatullina IK,Moustafine RI,Khutoryanskiy VV .2019 .Acrylated Eudragit® E PO as a novel polymeric excipient with enhanced mucoadhesive properties for application in nasal drug delivery. Int. J. Pharm., 562 : 241-248.
Pradhan R,Kim SY,Yong CS,Kim JO .2016 .Preparation and characterization of spray-dried valsartan-loaded Eudragit® E PO solid dispersion microparticles. Asian J. Pharm. Sci., 11(6) : 744-750.
Rajasekhar D,Srinivasulu D,Sridhar C,Kumar GVN,Ramesh P .2016 .Synthesis, Spectral Characterization and Antioxidant Activity of Novel Zafirlukast Sulfonyl Derivatives. J. Chin. Chem. Soc., 63(3) : 267-274.
Saeed MA,Ansari MT,Ch BA .2019 .Enhancement of solubility and dissolution profile of artesunate by employing solid dispersion approach: An in-vitro evaluation. Pak. J. Pharm. Sci., 36(Suppl) : 353-361.
Schierle S,Flauaus C,Heitel P,Willems S,Schmidt J,Kaiser A,Weizel L,Goebel T,Kahnt AS,Geisslinger G .2018 .Boosting anti-inflammatory potency of zafirlukast by designed polypharmacology. J. Med, 61(13) : 5758-5764.
Sheng X,Tang J,Bao J,Shi X,Su W .2018 .Enhancement of in vitro dissolution and in vivo performance/oral absorption of FEB-poloxamer-TPGS solid dispersion. J. Drug Deliv. Sci. Technol, 46 : 408-415.
Shi N-Q,Zhang Y,Li Y,Lai H-W X,Feng B,Qi X-R .2017 .Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms. Int. J. Pharm., 528(1-2) : 563-577.
Song Q,Hu Z,Xie X,Cai H X .2020 .Zafirlukast prevented ox-LDL-induced formation of foam cells. Toxicol. Appl, 409 : 115295.
Tambe A,Pandita N A .2018 .Enhanced solubility and drug release profile of boswellic acid using a poloxamer-based solid dispersion technique. J. Drug Deliv. Sci. Technol, 44 : 172-180.
Thakral S,Terban MW,Thakral NK,Suryanarayanan R .2016 .Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry. Adv. Drug Deliv. Rev., 100 : 183-193.
Yadav B,Tanwar Y .2016 .Development, characterization and in vitro evaluation of flurbiprofen solid dispersions using polyethylene glycols as carrier. J. App. Pharm. Sci., 6(04) : 060-066.
Yang L,Chen X,Ni K,Li Y,Wu J,Chen W,Ji Y,Feng L,Li F,Chen D F .2020 .Proton-exchanged montmorillonite-mediated reactions of hetero-benzyl acetates: Application to the synthesis of Zafirlukast. , 61(29) : 152123.
Yoon I,Han H,Kim J .2018 .Successful management of refractory cough with the leukotriene receptor antagonist zafirlukast in a dog with chronic bronchitis: a case report. Vet, 63(4) : 181-186.
Zeng C,Wang D,Chen C,Chen L,Chen B,Li L,Chen M,Xing H M .2020 .Zafirlukast protects blood-brain barrier integrity from ischemic brain injury. Chem. Biol. Interact, 316 : 108915.
0

Citations

0

Downloads

12

Views